Dr. Mari Aparici is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Palo Alto, CA 94305Phone+1 650-723-2325
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityResidency, Nuclear Medicine, 2003 - 2005
- Universidad de Valencia Faculty of MedicineClass of 1992
Certifications & Licensure
- CA State Medical License 2005 - 2025
- American Board of Nuclear Medicine Nuclear Medicine
Clinical Trials
- 68Ga Citrate PET/MRI for Evaluation of Fever of Unknown Origin (FUO) Start of enrollment: 2019 Jan 15
Roles: Contact, Sponsor-Investigator, Principal Investigator
- A Study to Evaluate Safety, Tolerability, Dosimetry, and Preliminary Efficacy of the HER2 Directed Radioligand CAM-H2 in Patients With Advanced/Metastatic HER2-Positive Breast, Gastric, and Gastro-Esophageal Junction (GEJ) Cancer Start of enrollment: 2021 Sep 14
Roles: Contact
- Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE Start of enrollment: 2021 Dec 21
Roles: Contact
Publications & Presentations
PubMed
- 31 citationsHigh-Specific-Activity-131I-MIBG versus 177Lu-DOTATATE Targeted Radionuclide Therapy for Metastatic Pheochromocytoma and Paraganglioma.Abhishek Jha, David Taïeb, Jorge A. Carrasquillo, Daniel A. Pryma, Mayank Patel
Clinical Cancer Research. 2021-03-08 - 27 citationsRadiotheranostics - Precision Medicine in Nuclear Medicine and Molecular Imaging.Heying Duan, Andrei Iagaru, Carina Mari Aparici
Nanotheranostics. 2022-01-01 - 13 citationsSPECT at the speed of PET: a feasibility study of CZT-based whole-body SPECT/CT in the postLu-DOTATATE andLu-PSMA617 setting.Hong Song, Valentina Ferri, Heying Duan, Carina Mari Aparici, Guido Davidzon
European Journal of Nuclear Medicine and Molecular Imaging. 2023-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: